CEP
NUVA

Chicago Equity Partners’s NuVasive, Inc. NUVA Stock Holding History

Chicago Equity Partners’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,765
Closed -$755K – 909
2019
Q4 		$755K Buy
+9,765
New +$689K 0.04% 536

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Chicago Equity Partners's NUVA Position: Q1 2020 in Review

Chicago Equity Partners sold out of NuVasive, Inc. (NUVA) in Q1 2020, closing a stake of 9,765 shares — an estimated $755K sold.

Chicago Equity Partners first reported a position in NUVA in Q4 2019 and held it in 1 quarter. The position peaked at $755K in Q4 2019. 266 funds tracked by Wall St. Rank hold NUVA as of Q1 2020.

  • Chicago Equity Partners reported no remaining NuVasive, Inc. position as of Q1 2020 after selling out during the quarter.
  • Chicago Equity Partners sold 9,765 NuVasive, Inc. shares in Q1 2020, an estimated $755K.
  • Chicago Equity Partners first reported a position in NuVasive, Inc. in Q4 2019 and held it in 1 quarter.
  • Chicago Equity Partners's NuVasive, Inc. position peaked at $755K in Q4 2019.
  • 266 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.